Islet cell antibodies at diagnosis, but not leanness, relate to a better cardiovascular risk factor profile 5 years after diagnosis of NIDDM

Diabetes Care

Volumn 19, Issue 1, 1996, Pages 60-63

  Gottsäter, Anders ^a   Ahmed, Mubarik ^a   Lilja, Bo ^a   Fernlund, Per ^a   Sundkvist, Göran ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PANCREAS ISLET CELL ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; LEAN BODY WEIGHT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROGNOSIS; PROTEIN URINE LEVEL; RISK FACTOR;

EID: 0030066408     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.1.60     Document Type: Article

References (27)

1. World Health Organization: Diabetes Mellitus Report of a WHO Study Group. Geneva, World Health Org , 1985 (Tech. Rep Ser., no. 727)
2. Landin-Olsson M, Nilsson K-O. Lernmark Å, Sundkvist G Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561-568, 1990
3. Niskanen L, Karjalamen J, Sarlund H, Siitonen O, Uusitupa M: Five-year follow up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34.402-408, 1991
4. Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark Å, Sundkvist G: β-cell function in relation to islet cell antibodies (ICA) during the first three years after the clinical diagnosis of diabetes in non-insulin-dependent (type II) diabetic patients. Diabetes Care 16:902-910, 1993
5. Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark Å: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1993
6. Tuomi T, Groop L, Zimmet P, Rowley M, Knowles W, Mackay I: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease Diabetes 42.359-362, 1993
7. Garcia M, McNamara P, Gordon T, Kannel W Morbidity and mortality in diabetics in the Framingham population. sixteen year follow-up study. Diabetes 23. 105-111, 1974
8. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 30:123-131, 1987
9. Reaven G: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
10. Jarrett RJ In defence of insulin: a critique of syndrome X. Lancet 340:469-471, 1992
11. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 288:1401-1404, 1984
12. Jeppsson J-O, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin Alc by a new liquid-chromatographic assay methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32.1867-1872, 1986
13. Heding LS. Radioimmunological determination of C-peptide in serum. Diabetologia 11:541-548, 1975
14. Burstein M, Scholnik HR, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11 583-595, 1970
15. Feldt-Rasmussen B, Mathiesen E, Hegedüs L, Deckert T: Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy N Engl J Med 314:665-670, 1986
16. Bröchner-Mortenson J: A simple method for determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271-274, 1972
17. Madsen OD, Landin-Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlqvist G, Ludvigsson J: A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies Diabetologia 29: 115-118, 1986
18. Landin-Olsson M, Sundkvist G, Lernmark Å: Prolonged incubation on the two-colour immunofluorescent test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:327-332, 1987
19. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categones of glucose intolerance. Diabetes 28:1039-1057, 1979
20. Medical Products Agency Treatment of hyperlipidemia (in Swedish). Information från Socialstyrelsens lākemedelsavdelning 5:152-157, 1988
21. Hollenbeck CB, Chen Y-DI, Greenfield MS, Lardinois CK, Reaven GM: Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 62:605-608, 1986
22. Vessby B, Boberg M, Hellsing K, Lithell H, Berne C: C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients. Diabetes Res 12: 109-116, 1989
23. Lindström T, Amqvist HJ, Olsson AG: Effects of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 81:137-144, 1990
24. Lindström T, Arnqvist H, Ludvigsson J, Von Schenk H: C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment. Acta Endocrinol 126:477-483, 1992
25. Mattock MB, Keen H, Viberti GC, El-Gohan MR, Murrells TJ, Scott GS, Wing JR, Jackson PG. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:82-87, 1988
26. Patrick AW, Leslie PJ, Clarke BF, Frier BM: The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 7:902-908, 1990
27. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16:996-1003, 1993